Varian releases planning tool
Radiotherapy giant Varian Medical Systems has begun marketing its latest treatment planning software for brachytherapy.
Radiotherapy giant Varian Medical Systems has begun marketing its latest treatment planning software for brachytherapy. VariSeed 7.0 helps physicians accurately deliver precise doses by providing access to real-time images generated during the implantation of radioactive seeds. The use of these seeds to treat prostate cancer has become increasingly common, producing results comparable to radical prostatectomy but with a lower risk of side effects such as impotence and incontinence. With VariSeed 7.0, radiation oncologists can generate a treatment plan, use it to implant the seeds, and see how the radiation dose will develop within the patient's anatomy while the patient is still in the operating room. This allows for fine-tuning and more precise adjustments on the spot, according to the company. VariSeed 7.0 also introduces the ability to superimpose different kinds of diagnostic images; SPECT, for example, can demonstrate the extent of disease, while CT and ultrasound show anatomy and positioning.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
